Bayer Aims to Expand HealthCare Portfolio - Analyst Blog
April 30 2013 - 10:50AM
Zacks
In a bid to strengthen its
contraceptive portfolio Bayer (BAYRY) inked a deal
to buy Conceptus Inc. (CPTS) for $31.00 per share
or approximately $1.1 billion in cash. Conceptus focuses on
developing and commercializing innovative device-based solutions in
permanent birth control.
Bayer intends to launch a public
tender offer to acquire all shares of Conceptus within the next 10
days. The transaction is expected to close by mid-2013.
Bayer’s impending acquisition of
Conceptus will add the Essure permanent (non-surgical) birth
control system to its product portfolio. We note that Conceptus’
Essure procedure was approved in 2002 in the US and is well
accepted in the market. Bayer’s contraceptive portfolio currently
includes drugs like Yasmin/Yaz and Mirena among others.
Successful completion of the
acquisition would ensure the presence of short-term, long-term and
permanent contraceptive choices for women in Bayer’s portfolio. The
Essure procedure is a strategic fit in Bayer’s HealthCare
business.
Bayer mentioned in its press
release that more than 700,000 women around the world have already
undergone this procedure. Conceptus reported net sales of $141
million for the year 2012.
The HealthCare segment recorded
revenues of €4.4 billion in the first quarter of 2013, up 2.3% year
over year. Bayer expects revenues from the HealthCare segment to
come in at around €19 billion in 2013.
We remind investors that the
contraceptive market has players like Teva Pharmaceutical
Industries Ltd. (TEVA).
Bayer, a large cap pharma company,
presently carries a Zacks Rank #4 (Sell). Other large cap pharma
companies such as Abbvie Inc. (ABBV) currently
look more attractive. Abbvie carries a Zacks Rank #2 (Buy).
ABBVIE INC (ABBV): Free Stock Analysis Report
BAYER A G -ADR (BAYRY): Free Stock Analysis Report
CONCEPTUS INC (CPTS): Free Stock Analysis Report
TEVA PHARM ADR (TEVA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Historical Stock Chart
From Jul 2023 to Jul 2024